Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022.
Ditsch N, Wöcke A, Untch M, Jackisch C, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, Dall P, Fallenberg EM, Fasching PA, Fehm TN, Friedrich M, Gerber B, Gluz O, Harbeck N, Heil J, Huober J, Kreipe HH, Krug D, Kühn T, Kümmel S, Kolberg-Liedtke C, Loibl S, Lüftner D, Lux MP, Maass N, Mundhenke C, Nitz U, Park-Simon TW, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Witzel I, Müller V, Janni W, Thill M. Ditsch N, et al. Among authors: rody a. Breast Care (Basel). 2022 Aug;17(4):403-420. doi: 10.1159/000524879. Epub 2022 May 5. Breast Care (Basel). 2022. PMID: 36156915 Free PMC article. Review.
[Systemic therapy of operable carcinoma of the breast].
Kaufmann M, Jonat W, Eiermann W, Costa S, Hilfrich J, Jänicke F, Beckmann MW, Wallwiener D, Gerber B, Rody A, Schneeweiss A, Nitz U, Köhler U, von Minckwitz G. Kaufmann M, et al. Among authors: rody a. Zentralbl Gynakol. 2005 Aug;127(4):207-12. doi: 10.1055/s-2005-836524. Zentralbl Gynakol. 2005. PMID: 16037900 German. No abstract available.
Use of goserelin in the treatment of breast cancer.
Rody A, Loibl S, von Minckwitz G, Kaufmann M. Rody A, et al. Expert Rev Anticancer Ther. 2005 Aug;5(4):591-604. doi: 10.1586/14737140.5.4.591. Expert Rev Anticancer Ther. 2005. PMID: 16111461 Review.
Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response.
Rody A, Karn T, Gätje R, Ahr A, Solbach C, Kourtis K, Munnes M, Loibl S, Kissler S, Ruckhäberle E, Holtrich U, von Minckwitz G, Kaufmann M. Rody A, et al. Breast. 2007 Feb;16(1):86-93. doi: 10.1016/j.breast.2006.06.008. Epub 2006 Sep 28. Breast. 2007. PMID: 17010609 Clinical Trial.
Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy.
Diallo-Danebrock R, Ting E, Gluz O, Herr A, Mohrmann S, Geddert H, Rody A, Schaefer KL, Baldus SE, Hartmann A, Wild PJ, Burson M, Gabbert HE, Nitz U, Poremba C. Diallo-Danebrock R, et al. Among authors: rody a. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):488-97. doi: 10.1158/1078-0432.CCR-06-1842. Clin Cancer Res. 2007. PMID: 17255270 Clinical Trial.
224 results